ENDRA Life Sciences Inc. - NDRA
Detailed investor-level table based on 13F positions.
Methodology:
Market value and % of portfolio use SEC reported VALUE ($000).
For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received.
Details.
Rows: 0
| Investor | History | Status | Shares held | Market value ($000) | % of portfolio | Previous % | Rank | Change in shares | % change in shares | Source | Date reported |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Altium Capital Management LLC | History | No change | 51,900 | 241 | 0.57% | 0.93% | 1 | 0 | 0.0% | Q1 2026 | May 01, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | History | New | 21,078 | 98 | 0.0% | — | 2 | +21,078 | New | Q1 2026 | May 15, 2026 |
| VANGUARD GROUP INC | History | No change | 12,937 | 58 | 0.0% | 0.0% | 3 | 0 | 0.0% | Q4 2025 | Jan 29, 2026 |
| VANGUARD FIDUCIARY TRUST CO | History | New | 10,121 | 47 | 0.0% | — | 4 | +10,121 | New | Q1 2026 | May 08, 2026 |
| MORGAN STANLEY | History | Reduced | 3,546 | 16 | 0.0% | 0.0% | 5 | -3,400 | -48.95% | Q1 2026 | May 15, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | History | New | 2,816 | 13 | 0.0% | — | 6 | +2,816 | New | Q1 2026 | May 15, 2026 |
| UBS Group AG | History | Added to | 152 | 0 | — | — | — | +140 | 1166.67% | Q1 2026 | May 05, 2026 |
| BANK OF AMERICA CORP /DE/ | History | Closed out | 0 | 0 | — | — | — | -10 | -100.0% | Q1 2026 | May 15, 2026 |
| Caitong International Asset Management Co., Ltd | History | New | 4 | 0 | — | — | — | +4 | New | Q1 2026 | May 11, 2026 |
| CITIGROUP INC | History | Closed out | 0 | 0 | — | — | — | -1 | -100.0% | Q1 2026 | May 11, 2026 |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | History | No change | 19 | 0 | — | — | — | 0 | 0.0% | Q1 2026 | May 07, 2026 |
| Gleason Group, Inc. | History | No change | 6,300 | 0 | — | — | — | 0 | 0.0% | Q1 2026 | May 04, 2026 |